| Cas No.: | 865466-24-6 |
| Chemical Name: | 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)- |
| Synonyms: | SCH 900518;SCH900518;SCH-900518 |
| SMILES: | CCCC[C@H](NC([C@H]1N(C([C@H](C(C)(C)C)NC(NC2(CS(C(C)(C)C)(=O)=O)CCCCC2)=O)=O)C[C@H]2[C@@H]1C2(C)C)=O)C(C(NC1CC1)=O)=O |
| Formula: | C36H61N5O7S |
| M.Wt: | 707.9639 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A potent, second generation HCV NS3 serine protease inhibitor with Ki of 6 nM; displays no significant issues in the in vitro CYP or hERG assay; shows replicon EC90 of 40 nM; exhibits improved potency (∼10-fold over Boceprevir), pharmacokinetic profile and physicochemical characteristics. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
